CPRX - Catalyst Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.75
DETAILS
HIGH:
$32.00
LOW:
$31.50
MEDIAN:
$31.75
CONSENSUS:
$31.75
UPSIDE:
0.83%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Smith | 844,887 | $20.9M | 0.2% | -2,518,920 | DECREASED |
| Wood | 425,865 | $10.5M | 0.0% | +425,865 | NEW |
| Greenblatt | 61,371 | $1.5M | 0.0% | -594 | DECREASED |
| Cooperman | 40,542 | $1.0M | 0.0% | +29,762 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-15 | DENKHAUS DONALD A | director | D-Return | 20,000 | $7.07 | $141K |
| 2026-07-15 | DENKHAUS DONALD A | director | D-Return | 15,000 | $18.59 | $279K |
| 2026-07-15 | DENKHAUS DONALD A | director | D-Return | 29,524 | $14.15 | $418K |
| 2026-07-15 | DENKHAUS DONALD A | director | D-Return | 23,248 | $21.12 | $491K |
| 2026-07-15 | DENKHAUS DONALD A | director | D-Return | 18,115 | $22.77 | $412K |
| 2026-07-15 | Del Carmen Jeffrey | officer: Chief Commercial Officer | D-Return | 137,553 | $21.12 | $2.9M |
| 2026-07-15 | Del Carmen Jeffrey | officer: Chief Commercial Officer | D-Return | 106,873 | $22.77 | $2.4M |
| 2026-07-15 | Del Carmen Jeffrey | officer: Chief Commercial Officer | D-Return | 32,257 | -- | -- |
| 2026-07-15 | Daly Richard J | director, officer: President and CEO | D-Return | 115,283 | -- | -- |
| 2026-07-15 | Kalb Michael Wayne | officer: Chief Financial Officer | D-Return | 13,665 | $31.50 | $430K |
| 2026-07-15 | Kalb Michael Wayne | officer: Chief Financial Officer | D-Return | 257,214 | $16.81 | $4.3M |
| 2026-07-15 | Kalb Michael Wayne | officer: Chief Financial Officer | D-Return | 169,248 | $21.12 | $3.6M |
| 2026-07-15 | Kalb Michael Wayne | officer: Chief Financial Officer | D-Return | 131,536 | $22.77 | $3.0M |
| 2026-07-15 | Kalb Michael Wayne | officer: Chief Financial Officer | D-Return | 39,701 | -- | -- |
| 2026-07-15 | DENKHAUS DONALD A | director | D-Return | 5,468 | -- | -- |
| 2026-07-15 | Del Carmen Jeffrey | officer: Chief Commercial Officer | D-Return | 14,337 | $31.50 | $452K |
| 2026-07-15 | Del Carmen Jeffrey | officer: Chief Commercial Officer | D-Return | 150,000 | $4.70 | $705K |
| 2026-07-15 | Del Carmen Jeffrey | officer: Chief Commercial Officer | D-Return | 200,000 | $3.42 | $684K |
| 2026-07-15 | Del Carmen Jeffrey | officer: Chief Commercial Officer | D-Return | 135,000 | $7.07 | $954K |
| 2026-07-15 | Del Carmen Jeffrey | officer: Chief Commercial Officer | D-Return | 88,000 | $18.59 | $1.6M |
| 2026-07-15 | Andrews William T. | officer: Chief Medical Officer | D-Return | 2,309 | $31.50 | $73K |
| 2026-07-15 | Del Carmen Jeffrey | officer: Chief Commercial Officer | D-Return | 167,918 | $14.15 | $2.4M |
| 2026-07-15 | Harper Molly | director | D-Return | 5,468 | -- | -- |
| 2026-07-15 | Elsbernd Brian | officer: Chief Legal Officer | D-Return | 242,501 | $31.50 | $7.6M |
| 2026-07-15 | Elsbernd Brian | officer: Chief Legal Officer | D-Return | 132,000 | $4.64 | $612K |